CHANGES IN THE BOARD OF DIRECTORS OF MEDACTA GROUP SA
CASTEL SAN PIETRO, 18 March 2020 - Medacta announces that due to his various other commitments, Mr. Marco Gadola will not stand for re-election to the board of directors of Medacta Group SA at the forthcoming annual general meeting scheduled for 19 May 2020. Medacta wishes to thank Mr. Gadola for his contribution and wishes him all the best for his future endeavours. At present Medacta has no plan to nominate a substitute for Mr. Gadola but will consider this in the preparations of the forthcoming annual general meeting of Medacta.
Medacta Group SA
Corrado Farsetta, CFO
Phone: +41 91 696 60 60
Medacta is an international company specializing in the design and production of innovative orthopaedic products and the development of accompanying surgical techniques for joint replacement, spine surgery, and sports medicine. Established in 1999 in Switzerland, Medacta's products and surgical techniques are characterized by innovation. Medacta is a pioneer in developing new offerings on the basis of minimally invasive surgical techniques, in particular its Anterior Minimally Invasive Surgery ('AMIS') technique for hip replacements. Medacta has leveraged its orthopaedic expertise and comprehensive understanding of the human body to develop the sophisticated 'MySolutions' technology, which offers surgeons highly personalized pre-operative planning and implant placement methodologies by creating advanced personalized kinematic models and 3D planning tools for use in hip, knee, shoulder and spine procedures.